Renovaro Obtains a U.S. Patent for its AI-Powered Platform for Medication Discovery and Diagnostics
Renovaro Inc. (NASDAQ:RENB) declared that the U.S.
Renovaro Inc. (RENB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 166,083 | $90,216 | 0% | |
| 2. | 23,300 | $12,657 | -53% | 0% | |
| 3. | AQR Capital Management Cliff Asness | 20,004 | $10,867 | +91% | 0% |
| 4. | Millennium Management Israel Englander | 14,544 | $7,900 | 0% | |
| 5. | 8,000 | $4,346 | +87% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.00 | 128,493 | $1,027,944.00 | 128,493 | 2022-05-18 | Filing | |
| $8.00 | 125,000 | $1,000,000.00 | 125,000 | 2022-05-18 | Filing | |
| $6.70 | 31,500 | $211,050.00 | 6,576,044 | 2019-06-04 | Filing | |
| $6.61 | 36,200 | $239,282.00 | 6,484,544 | 2019-05-28 | Filing | |
| $6.70 | 40,000 | $268,000.00 | 6,544,544 | 2019-06-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.30 | 1,114 | $1,448.20 | 840,319 | 2024-07-29 | Filing | |
| $1.46 | 16,362 | $23,888.52 | 841,433 | 2024-07-17 | Filing | |
| $1.41 | 21,954 | $30,955.14 | 875,795 | 2024-07-15 | Filing | |
| $1.51 | 14,896 | $22,492.96 | 897,749 | 2024-07-11 | Filing | |
| $1.51 | 75,000 | $113,250.00 | 894,645 | 2024-07-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,100 | $4,651 | 0% | |
| 2. | 14,515 | $4,193 | 0% | |
| 3. | 13,025 | $3,812 | 0% | |
| 4. | 12,001 | $3,467 | 0% | |
| 5. | 1,464 | $423 | 0% |
News See All
Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger
A binding merger agreement signed on January 1, 2025, which called for Predictive Oncology to merge into Renovaro Inc.
11 AI News and Ratings You Probably Missed
According to a February research report by Precedence Research, the global AI market is projected to grow from $757.58 billion in 2025 to approximately $3.68 trillion by 2034, with a compound annual growth...
18 AI News and Ratings Making Waves on Wall Street
In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in enterprise adoption, and...
12 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023.
Billionaire Hedge Funds
